Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission

Authors:

Abstract
No abstract available
Funding Information
  • National Key Research and Development Program of China (2018AAA0100302)
  • National Key Research and Development Program of China (2023YJBF-GG02)
  • National Key Research and Development Program of China (2023YFC3402000)
  • National Natural Science Foundation of China (82330055)
  • National Natural Science Foundation of China (32270960)
  • National Natural Science Foundation of China (82320108010)
  • National Natural Science Foundation of China (81930043)
  • National Natural Science Foundation of China (U24A20380)
  • National Natural Science Foundation of China (31821003)
  • National Natural Science Foundation of China (82271852)
  • National Natural Science Foundation of China (82271816)
  • Natural Science Foundation of Jiangsu Province (BK20231119)
  • Shanghai Municipal Health Commission
  • Nanjing Drum Tower Hospital
  • Jiangsu Commission of Health
  • Science and Technology Commission of Shanghai Municipality (23XD1430600)
  • Basic Research Program of Jiangsu Province (BK20243061)

This publication has 25 references indexed in Scilit: